Sebikhan Plus Tablets 5/20/12.5 mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Korea Sintex Pharmaceuticals Co., Ltd.
MFDS item code 201907667 · Approved 2019.11.01
This product's status changed to Expired on 2024.11.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
This medication is used in patients with essential hypertension who are not adequately controlled with single-drug therapy, utilizing a combination of Amlodipine and Olmesartan Medoxomil. The two drugs work together to dilate blood vessels and effectively lower blood pressure, thereby helping to improve hypertension.
Take 1 tablet once daily with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine and olmesartan medoxomil, as monotherapy or combination therapy). However, if blood pressure is not controlled with the combination of amlodipine and olmesartan medoxomil, a direct switch to this medicine may be considered as follows. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. - 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. - 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose-escalation schedule. (The strength of each component is listed in the order of amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg Patients with renal impairment The maximum dose of this medicine for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). Patients with hepatic impairment Use with caution in patients with mild or moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. Older adults (65 years and older) In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in older adults. Since there is very limited experience with the use of this medicine in older adults aged 75 years and older, monitor them very carefully during treatment.
Under 18 years of age: Safety and efficacy have not been established; use of this medicine is not recommended.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be stopped immediately if pregnancy is confirmed. Do not take this medication if you are allergic to it or any of its components, are pregnant or breastfeeding, or have severe hypotension or problems with heart, kidney, or liver function. Patients with low blood volume or decreased salt levels may develop hypotension, so they should be carefully monitored before taking this medication, and appropriate actions should be taken as necessary. Patients with poor renal function or kidney transplant recipients should regularly monitor their renal function and electrolyte levels with blood tests, and this medication is not recommended for patients with severe renal impairment. Patients with liver disease or diminished liver function may require dosage adjustments, and it is best not to use this medication in patients with severe liver impairment. This medication lowers blood pressure, which may cause dizziness or lightheadedness; caution is advised when driving or operating dangerous machinery. This medication may interact with other drugs, particularly lithium, non-steroidal anti-inflammatory drugs, and other blood pressure medications, so caution is necessary when used together. Blood tests to monitor electrolytes and renal function should be conducted regularly while taking this medication, and any unusual symptoms should be reported to a healthcare professional immediately. If breastfeeding, it is recommended to stop nursing or discontinue this medication as its components can be passed into breast milk. It is not recommended for use in children under 18 years of age, as safety and efficacy have not been established. Elderly patients may have a more sensitive drug response due to renal function decline, so starting at a lower dose and careful monitoring is advised. In case of overdose, severe hypotension and heart rhythm abnormalities may occur, necessitating immediate contact with healthcare personnel and appropriate treatment. Store this medication protected from moisture, heat, and light, and keep it out of reach of children. It is advisable not to transfer it to another container. During treatment, the skin may become sensitive to sunlight, so it is important to pay attention to UV protection, and consult a professional if any skin abnormalities occur.
Peripheral edema, headache, dizziness, upper respiratory infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, loss of appetite, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, apathy, sensitivity to stimulation, agitation, mood changes, sleep disorders, orthostatic dizziness, syncope, taste disturbances, hypertonia, sensory impairment, paresthesia, peripheral neuropathy, drowsiness, fainting, convulsions, loss of appetite, tremor, visual disturbances, decreased tear production, worsening myopia, jaundice, dizziness, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, dyspnea, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, changes in bowel habits, abdominal distension, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like reactions, pustular dermatitis, exfoliative dermatitis, hyperhidrosis, photosensitivity reactions, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, skin discoloration, Stevens-Johnson syndrome, urticaria, muscle spasms, joint edema, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, increased frequency of urination, acute renal failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, ennui, edema, pain, facial swelling, elevated serum creatinine, elevated blood urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated serum creatinine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, altered consciousness, drug hypersensitivity, epigastric pain, decreased libido, facial edema, asthenia, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, acute respiratory distress syndrome (ARDS)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage helps to ensure the effectiveness and safety of the medication.
White-orange round film-coated tablets
30 tablets/box[(10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Korea Sintex Pharmaceuticals Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.